Prime editing system offers wide range of versatility in human cells, correcting disease-causing genetic variations A team from the Broad Institute of MIT and Harvard has developed a new CRI... Read more
Researchers at Western University have developed a new way to deliver the DNA-editing tool CRISPR-Cas9 into microorganisms in the lab, providing a way to efficiently launch a targeted attack... Read more
Successful T cell engineering with gene scissors The idea of genetically modifying a patient’s own immune cells and deploying them against infections and tumors has been around since the 198... Read more
An international team of biologists urge careful use of technology in research and flag potential biosafety risks. The use of gene-editing technology to create virus-resistant cassava plants... Read more
The advance of science is something like the wandering of an explorer through an uncharted jungle. Often, the dense undergrowth can seem impenetrable, but at certain privileged moments, a cl... Read more
ETH researchers have integrated two CRISPR-Cas9-based core processors into human cells. This represents a huge step towards creating powerful biocomputers. Controlling gene expression throug... Read more
A team of engineers at the UC Berkeley and the Keck Graduate Institute (KGI) of The Claremont Colleges combined CRISPR with electronic transistors made from graphene to create a new hand-hel... Read more
Putting the brakes on aging Aging is a leading risk factor for a number of debilitating conditions, including heart disease, cancer and Alzheimer’s disease, to name a few. This makes the nee... Read more
Genetic edits and protein restoration in mouse models of Duchenne muscular dystrophy remain viable one year after single CRISPR treatment Researchers at Duke University have shown that a sin... Read more
Technique Prevents Transplant Rejection in the Lab, a Major Advance for Stem Cell Therapies UC San Francisco scientists have used the CRISPR-Cas9 gene-editing system to create the first plur... Read more
GW researchers successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, affecting more than a quarter of a billion people in Southeast Asia, sub-Sahara... Read more
